tiprankstipranks
Advertisement
Advertisement

ESLA Stock Latest News

Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment
Company AnnouncementsEstrella Immunopharma Shareholders Ratify 2026 Auditor Appointment
22d ago
8K
ESLA
Estrella Immunopharma presents updated data on EB103
PremiumThe Fly
Estrella Immunopharma presents updated data on EB103
5M ago
ESLA
Estrella Immunopharma Receives Nasdaq Non-Compliance Notice
PremiumCompany Announcements
Estrella Immunopharma Receives Nasdaq Non-Compliance Notice
6M ago
8K
ESLA
Estrella Immunopharma completes $8M direct offering financing
PremiumCompany Announcements
Estrella Immunopharma completes $8M direct offering financing
7M ago
8K
ESLA
Estrella Immunopharma files to sell 2.54M shares of common stock for holders
PremiumThe Fly
Estrella Immunopharma files to sell 2.54M shares of common stock for holders
7M ago
ESLA
Estrella Immunopharma Advances STARLIGHT-1 Trial to Phase II
PremiumCompany AnnouncementsEstrella Immunopharma Advances STARLIGHT-1 Trial to Phase II
8M ago
8K
ESLA
Estrella Immunopharma advances STARLIGHT-1 trial after DSMB review
Premium
The Fly
Estrella Immunopharma advances STARLIGHT-1 trial after DSMB review
8M ago
ESLA
Estrella Immunopharma Achieves Milestone in STARLIGHT-1 Trial
Premium
Company Announcements
Estrella Immunopharma Achieves Milestone in STARLIGHT-1 Trial
9M ago
8K
ESLA
Estrella Immunopharma completes second dose cohort in STARLIGHT-1 trial
PremiumThe Fly
Estrella Immunopharma completes second dose cohort in STARLIGHT-1 trial
9M ago
ESLA
Estrella Immunopharma regains compliance with Nasdaq
PremiumThe Fly
Estrella Immunopharma regains compliance with Nasdaq
10M ago
ESLA
Estrella Immunopharma Regains Nasdaq Compliance
PremiumCompany Announcements
Estrella Immunopharma Regains Nasdaq Compliance
10M ago
8K
ESLA
Estrella Immunopharma Appoints Jia Dengyao to Board
PremiumCompany Announcements
Estrella Immunopharma Appoints Jia Dengyao to Board
10M ago
8K
ESLA
Estrella Immunopharma Faces Nasdaq Non-Compliance Notice
PremiumCompany AnnouncementsEstrella Immunopharma Faces Nasdaq Non-Compliance Notice
12M ago
8K
ESLA
Estrella Immunopharma announces additional site for STARLIGHT-1 trial
Premium
The Fly
Estrella Immunopharma announces additional site for STARLIGHT-1 trial
1y ago
ESLA
Estrella Immunopharma Expands STARLIGHT-1 Clinical Trial
Premium
Company Announcements
Estrella Immunopharma Expands STARLIGHT-1 Clinical Trial
1y ago
8K
ESLA
Estrella Immunopharma Raises $3.35M in Private Placement
PremiumCompany Announcements
Estrella Immunopharma Raises $3.35M in Private Placement
1y ago
8K
ESLA
Estrella Immunopharma to sell 2.333M shares at $1.50 in private placement
PremiumThe Fly
Estrella Immunopharma to sell 2.333M shares at $1.50 in private placement
1y ago
ESLA
Estrella Immunopharma Advances STARLIGHT-1 Clinical Trial
PremiumCompany Announcements
Estrella Immunopharma Advances STARLIGHT-1 Clinical Trial
1y ago
8K
ESLA
Estrella Immunopharma doses first patient in second cohort of STARLIGHT-1 trial
PremiumThe Fly
Estrella Immunopharma doses first patient in second cohort of STARLIGHT-1 trial
1y ago
ESLA
Estrella Immunopharma completes first dose cohort in STARLIGHT trial
PremiumThe FlyEstrella Immunopharma completes first dose cohort in STARLIGHT trial
1y ago
ESLA
Estrella Immunopharma initiated with a Buy at D. Boral Capital
Premium
The Fly
Estrella Immunopharma initiated with a Buy at D. Boral Capital
1y ago
ESLA
Estrella Immunopharma files $100M common stock, warrants offering
Premium
The Fly
Estrella Immunopharma files $100M common stock, warrants offering
2y ago
ESLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >